A detailed history of Deutsche Bank Ag\ transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 49,567 shares of AVIR stock, worth $158,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,567
Previous 32,449 52.75%
Holding current value
$158,118
Previous $107,000 55.14%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.17 - $4.02 $54,264 - $68,814
17,118 Added 52.75%
49,567 $166,000
Q2 2024

Aug 14, 2024

SELL
$3.31 - $4.04 $26,284 - $32,081
-7,941 Reduced 19.66%
32,449 $107,000
Q1 2024

May 15, 2024

BUY
$3.09 - $4.56 $5,917 - $8,732
1,915 Added 4.98%
40,390 $163,000
Q4 2023

Feb 14, 2024

SELL
$2.8 - $3.35 $5,171 - $6,187
-1,847 Reduced 4.58%
38,475 $117,000
Q3 2023

Nov 09, 2023

BUY
$3.0 - $3.79 $9,009 - $11,381
3,003 Added 8.05%
40,322 $120,000
Q2 2023

Aug 14, 2023

SELL
$3.21 - $5.06 $63,837 - $100,628
-19,887 Reduced 34.76%
37,319 $139,000
Q1 2023

May 15, 2023

BUY
$3.0 - $4.97 $77,166 - $127,838
25,722 Added 81.7%
57,206 $191,000
Q4 2022

Feb 13, 2023

BUY
$4.35 - $6.17 $2,218 - $3,146
510 Added 1.65%
31,484 $151,000
Q3 2022

Nov 14, 2022

SELL
$5.49 - $8.79 $1.29 Million - $2.07 Million
-235,604 Reduced 88.38%
30,974 $176,000
Q2 2022

Aug 11, 2022

BUY
$5.33 - $8.18 $105,448 - $161,833
19,784 Added 8.02%
266,578 $1.89 Million
Q1 2022

May 13, 2022

BUY
$5.5 - $9.19 $954,684 - $1.6 Million
173,579 Added 237.08%
246,794 $1.78 Million
Q4 2021

Feb 11, 2022

SELL
$7.67 - $44.59 $158,707 - $922,656
-20,692 Reduced 22.03%
73,215 $654,000
Q3 2021

Nov 04, 2021

BUY
$21.33 - $35.06 $1.18 Million - $1.93 Million
55,150 Added 142.3%
93,907 $3.29 Million
Q2 2021

Aug 11, 2021

BUY
$19.22 - $59.08 $558,302 - $1.72 Million
29,048 Added 299.19%
38,757 $833,000
Q1 2021

May 13, 2021

SELL
$41.42 - $88.44 $36,656 - $78,269
-885 Reduced 8.35%
9,709 $599,000
Q4 2020

Feb 16, 2021

BUY
$26.36 - $41.78 $279,257 - $442,617
10,594 New
10,594 $443,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $266M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.